Max Chat
Share chart DarioHealth Corp.
Extended chart
Simple chart
About DarioHealth Corp.
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Main settings
IPO date
2014-10-06
ISIN
US23725P2092
Industry
Health Care Equipment & Supplies
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 1.95 | 7 |
| P/BV | 0.7331 | 10 |
| P/E | 1.29 | 10 |
Efficiency
| Title | Value | Grade |
| ROA | 38.07 | 9 |
| ROE | 62.97 | 10 |
| ROIC | 0 | 0 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -0.5229 | 10 |
| Debt/Ratio | 0.254 | 10 |
| Debt/Equity | 0.6507 | 9 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 255.79 | 10 |
| Yield Ebitda, % | 91.21 | 9 |
| Yield EPS, % | -112.55 | 0 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 0.666 $ | 0 $ | 0 $ | +0 % | 0 % | 0 % |
| Week | 0.72 $ | 0 $ | 0 $ | -7.5 % | 0 % | 0 % |
| Month | 0.7196 $ | 0.666 $ | 0.666 $ | -7.45 % | 0 % | 0 % |
| Three month | 0.7256 $ | 0.655 $ | 0.82 $ | -8.21 % | 0 % | 0 % |
| Half a year | 0.6886 $ | 0.556 $ | 0.82 $ | -3.28 % | 0 % | 0 % |
| Year | 0.82 $ | 0.556 $ | 1.53 $ | -18.78 % | 0 % | 0 % |
| 3 years | 4.76 $ | 0.556 $ | 7.16 $ | -86.01 % | 0 % | 0 % |
| 5 years | 13.84 $ | 0.556 $ | 30.42 $ | -95.19 % | 0 % | 0 % |
| 10 years | 0.2037 $ | 0.2037 $ | 30.42 $ | +326.95 % | 0 % | 0 % |
| Year to date | 0.6552 $ | 0.556 $ | 1.53 $ | +1.65 % | 0 % | 0 % |
Main owners
| Institutions | Volume | Share, % |
| Nantahala Capital Management, LLC | 4 673 506 | 15.87 |
| Appian Way Asset Management LP | 1 322 444 | 4.49 |
| Y.D. More Investments Ltd | 1 288 518 | 4.38 |
| Phoenix Holdings Ltd. | 1 180 813 | 4.01 |
| Clal Insurance Enterprises Holdings Ltd | 875 964 | 2.98 |
| Vanguard Group Inc | 363 042 | 1.23 |
| Geode Capital Management, LLC | 270 573 | 0.92 |
| Clarity Capital Partners LLC | 170 426 | 0.58 |
| Blackrock Inc. | 112 619 | 0.38 |
| LPL Financial LLC | 109 901 | 0.37 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Erez Raphael | CEO & Director | 722.19k | 1973 (52 years) |
| Dov Oppenheim | Co-Founder & Production Chief | N/A | |
| Josh Fischer | Senior Vice President of Operations & Compliance | N/A | |
| Claudia Levi | Content & Communications Manager | N/A | |
| Mr. Jean Christophe Muyl | Head of Commercialization North America | N/A | |
| Mr. Tomer Ben-Kiki | Chief Technology Officer | N/A | 1971 (54 years) |
| Limor Drezner | Chief People Officer | N/A | |
| Mr. Zvi Ben David CPA | CFO, Treasurer & Secretary | 342.58k | 1961 (64 years) |
| Kat Parrella | Investor Relations Manager | ||
| Ms. Mona Dean | Chief Compliance Officer |
About company
Address: United States, New York. NY, 18 West 18th Street - Open in google maps, Open in yandex maps
Website: https://www.dariohealth.com
Website: https://www.dariohealth.com
